The Global HIV
Vaccine Enterprise

is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by:

  • Shared scientific plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery, product development and manufacturing, and clinical trials
  • Increased resources: Mobilizing significant new funding to achieve the scientific plan
  • Greater collaboration: Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts

The Enterprise Approach 

Work for
the Enterprise

Learn more in Careers 

AIDS Vaccine 2009 - Paris, France 19-22 October

Update on the
2010 Scientific
Strategic Plan

Review the Updated Plan

Latest News:

Dianne Stewart, Formerly of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Joins IAVI as Vice President of Resource Development – August 19, 2009

Dianne Stewart, former head of Board and Donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Resource Development. In her role at IAVI, Ms. Stewart will provide leadership for the organization’s fundraising strategy focused on both the public and private sectors. For more information, please see the press release below.
Dianne Stewart Joins IAVI - August 19, 2009

Call for Applications: Standardized Measurement of Neutralizing Antibodies to Advance HIV Vaccine Development: An OCTAVE Workshop for Early Stage Investigators - August 6, 2009

The OCTAVE Project -- Online Collaborative Training for AIDS Vaccine Evaluation -- is organizing a workshop on October 18 and 19 at AIDS Vaccine 2009 that focuses on analysis and assays of antibodies in HIV Vaccine Research. The workshop will blend novel eLearning exercises in advance of an interactive, face-to-face 1.5 day workshop for early stage investigators selected to participate.

Early career investigators with interest in neutralizing antibodies and/or vaccine trials are encouraged to submit a CV and a 250 word statement of interest to . For more information, please visit the link below.
OCTAVE Satellite

The National Institute of Allergy and Infectious Diseases (NIAID) Seeks Candidates for Chief of Vaccine Discovery Branch – August 3, 2009

The NIAID seeks outstanding candidates for the newly created position of chief of the Vaccine Discovery Branch in the Vaccine Research Program of the Division of AIDS (DAIDS). The selected individual will serve as a Health Scientist Administrator (Branch Chief) with responsibility for planning, developing, implementing, and evaluating an extramural program of grants and contracts in basic HIV vaccine discovery research.

For more information, please visit the link below.
NIH Posting

New Funding Opportunity: The Global Health Research Initiative and the Canadian HIV Vaccine Initiative Launch a New Program to Build Sustainable African Capacity and Leadership in Clinical and Prevention Trials - July 30, 2009

The new program, which will focus on innovations in HIV prevention technologies, particularly HIV vaccines, offers a new funding opportunity for interested researchers. For more information, including the Letter Of Intent for this funding opportunity, please visit the link below.
Funding Opportunity Announcement

Global HIV Vaccine Enterprise Holds Face-to-Face Meeting of the Young and Early Career Investigators (YECI) Committee – July 28, 2009

The minutes from the July 27 and 28 meeting of the YECI Committee can be found below.
YECI Meeting Minutes – July 27 and 28, 2009

More News from the Enterprise 

All Content ©2005 - 2009 Global HIV Vaccine Enterprise